LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

Search

Quanterix Corp

Închisă

SectorSănătate

5.84 -0.17

Rezumat

Modificarea prețului

24h

Curent

Minim

5.63

Maxim

6.02

Indicatori cheie

By Trading Economics

Venit

10M

-23M

Vânzări

3.7M

44M

Marjă de profit

-52.712

Angajați

471

EBITDA

6.7M

-25M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+18.48% upside

Dividende

By Dow Jones

Următoarele câștiguri

11 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

58M

296M

Deschiderea anterioară

6.01

Închiderea anterioară

5.84

Sentimentul știrilor

By Acuity

57%

43%

297 / 351 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Quanterix Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

4 mar. 2026, 23:39 UTC

Acțiuni populare

Stocks to Watch: Broadcom, StubHub, PepGen, Veeva Systems

4 mar. 2026, 23:20 UTC

Câștiguri

Broadcom Sales Rise as AI Developers Build More Products and Agents -- Update

4 mar. 2026, 21:43 UTC

Câștiguri

Broadcom Logs Higher Sales, Authorizes $10 Billion Buyback Amid Climbing AI Demand

4 mar. 2026, 23:48 UTC

Market Talk

Nikkei May Rise After Recent Selloffs -- Market Talk

4 mar. 2026, 23:33 UTC

Market Talk
Evenimente importante

Gold Edges Higher Amid Ongoing U.S.-Iran Conflict -- Market Talk

4 mar. 2026, 23:24 UTC

Market Talk

RBA on Track to Raise Rates, but What's the Rush? -- Market Talk

4 mar. 2026, 22:30 UTC

Câștiguri

Ecopetrol: Distribution Equivalent to a Payout of 50.1% of Ecopetrol S.A.'s Net Income in 2025 >EC

4 mar. 2026, 22:30 UTC

Câștiguri

Ecopetrol: Payment of Dividends Proposed to Be Made No Later Than April 30 >EC

4 mar. 2026, 22:30 UTC

Câștiguri

Ecopetrol: Earnings Distribution Proposes Ordinary Div Distribution of COP110 per Shr >EC

4 mar. 2026, 22:13 UTC

Câștiguri

Vermilion Energy: Expects Full-Yr Production of 118,000 to 122,000 Boe/d (70% Natural Gas) >VET

4 mar. 2026, 22:13 UTC

Câștiguri

Vermilion Energy: Expects 1Q Production to Avg 122,000 to 124,000 Boe/d (70% Natural Gas) >VET

4 mar. 2026, 22:13 UTC

Câștiguri

Vermilion Energy 4Q EPS C$2.86 >VET

4 mar. 2026, 22:04 UTC

Market Talk

RBA Slipping Behind The Curve On Rates -- Market Talk

4 mar. 2026, 21:53 UTC

Câștiguri

Lithium Americas 4Q Rev $66.8M >LAC

4 mar. 2026, 21:53 UTC

Câștiguri

Lithium Americas 4Q Loss/Shr 52c >LAC

4 mar. 2026, 21:52 UTC

Câștiguri

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 mar. 2026, 21:50 UTC

Câștiguri

These Stocks Are Today's Movers: Moderna, Coinbase, Strategy, CoreWeave, Micron, Sandisk, GitLab, and More -- Barrons.com

4 mar. 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

4 mar. 2026, 21:48 UTC

Câștiguri

Webull 4Q Rev $165.2M >BULL

4 mar. 2026, 21:48 UTC

Câștiguri

Webull 4Q EPS 1c >BULL

4 mar. 2026, 21:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

4 mar. 2026, 21:45 UTC

Market Talk

Canada Officials Might Need to Intervene to Spur Home Building -- Market Talk

4 mar. 2026, 21:40 UTC

Câștiguri

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 mar. 2026, 21:36 UTC

Evenimente importante

Iran Conflict Spurs Rebound in U.S. Borrowing Costs -- Update

4 mar. 2026, 21:27 UTC

Câștiguri

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 mar. 2026, 21:17 UTC

Market Talk

Energy Price Volatility Boosts Case for Climate-Tech Startups -- Market Talk

4 mar. 2026, 21:16 UTC

Câștiguri

Broadcom: Board Authorizes Share-Repurchase Program for Up to $10B of Common Stock >AVGO

4 mar. 2026, 21:15 UTC

Câștiguri

Broadcom 1Q EPS $1.50 >AVGO

4 mar. 2026, 21:15 UTC

Câștiguri

Broadcom 1Q Net $7.35B >AVGO

4 mar. 2026, 21:15 UTC

Câștiguri

Broadcom 1Q Rev $19.31B >AVGO

Comparație

Modificare preț

Quanterix Corp Așteptări

Obiectiv de preț

By TipRanks

18.48% sus

Prognoză pe 12 luni

Medie 7.5 USD  18.48%

Maxim 8 USD

Minim 7 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruQuanterix Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

2 ratings

0

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

5.34 / 6.015Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

297 / 351 Clasament în Sănătate

Sentimentul știrilor

Evidențe de scădere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat